Literature DB >> 21058022

Residual renal function assessment with cystatin C.

Guido Filler, Shih-Han S Huang, Robert M Lindsay.   

Abstract

Su Jin Kim and coworkers from Korea published an important study on the relationship of residual renal function (RRF) and cystatin in pediatric peritoneal dialysis (PD) patients in this issue of Pediatric Nephrology, both in anuric patients and patients with RRF. Based on a lack of correlation between cystatin C and standard small solute-based dialysis adequacy parameters such as Kt/Vurea but a significant correlation with RRF, the authors concluded that cystatin C may be a good tool to monitor RRF. The editorial reviews the available literature in adults, the different handing between urea and cystatin C, and the determinants of cystatin C clearance in dialysis patients. In adults, cystatin C levels are determined predominantly by RRF, but not exclusively. In anephric hemodialysis and PD patients, there is a correlation with standard weekly Kt/Vurea. Cystatin C levels will also depend on ultrafiltration. Despite these factors that affect cystatin C levels beyond RRF, cystatin C is a useful parameter for monitoring PD patients that may be more closely related to long-term outcomes than small solute adequacy parameters.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21058022     DOI: 10.1007/s00467-010-1672-1

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  16 in total

1.  Cystatin C measurements in the assessment of residual renal function, dialysis adequacy, and beyond.

Authors:  Robert M Lindsay; Shih-Han Huang; Guido Filler
Journal:  Perit Dial Int       Date:  2010 Jul-Aug       Impact factor: 1.756

2.  Cystatin C intrapatient variability in children with chronic kidney disease is less than serum creatinine.

Authors:  Aarathi S Sambasivan; Nathalie Lepage; Guido Filler
Journal:  Clin Chem       Date:  2005-11       Impact factor: 8.327

3.  Superior dialytic clearance of beta(2)-microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal dialysis.

Authors:  P Evenepoel; B Bammens; K Verbeke; Y Vanrenterghem
Journal:  Kidney Int       Date:  2006-07-05       Impact factor: 10.612

4.  Prevalence of histological beta2-microglobulin amyloidosis in CAPD patients compared with hemodialysis patients.

Authors:  M Jadoul; C Garbar; R Vanholder; J Sennesael; C Michel; A Robert; H Noël; C van Ypersele de Strihou
Journal:  Kidney Int       Date:  1998-09       Impact factor: 10.612

5.  Estimation of residual glomerular filtration rate in dialysis patients from the plasma cystatin C level.

Authors:  Frans J Hoek; Johanna C Korevaar; Friedo W Dekker; Elisabeth W Boeschoten; Raymond T Krediet
Journal:  Nephrol Dial Transplant       Date:  2007-04-01       Impact factor: 5.992

6.  Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study.

Authors:  Joanne M Bargman; Kevin E Thorpe; David N Churchill
Journal:  J Am Soc Nephrol       Date:  2001-10       Impact factor: 10.121

7.  Serum cystatin C for estimation of residual renal function in children on peritoneal dialysis.

Authors:  Su Jin Kim; Young Bae Sohn; Sung Won Park; Dong-Kyu Jin; Kyung Hoon Paik
Journal:  Pediatr Nephrol       Date:  2010-11-11       Impact factor: 3.714

8.  Relationship of serum cystatin C to peritoneal and renal clearance measures in peritoneal dialysis: a cross-sectional study.

Authors:  Michael P Delaney; Paul E Stevens; Mohammed Al Hasani; Helen J Stowe; Caroline Judge; Edmund J Lamb
Journal:  Am J Kidney Dis       Date:  2008-02       Impact factor: 8.860

9.  Effect of dialysis dose and membrane flux in maintenance hemodialysis.

Authors:  Garabed Eknoyan; Gerald J Beck; Alfred K Cheung; John T Daugirdas; Tom Greene; John W Kusek; Michael Allon; James Bailey; James A Delmez; Thomas A Depner; Johanna T Dwyer; Andrew S Levey; Nathan W Levin; Edgar Milford; Daniel B Ornt; Michael V Rocco; Gerald Schulman; Steve J Schwab; Brendan P Teehan; Robert Toto
Journal:  N Engl J Med       Date:  2002-12-19       Impact factor: 91.245

10.  Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study.

Authors:  E G Lowrie; N M Laird; T F Parker; J A Sargent
Journal:  N Engl J Med       Date:  1981-11-12       Impact factor: 91.245

View more
  6 in total

1.  Serum β-trace protein and risk of mortality in incident hemodialysis patients.

Authors:  Tariq Shafi; Rulan S Parekh; Bernard G Jaar; Laura C Plantinga; Pooja C Oberai; John H Eckfeldt; Andrew S Levey; Neil R Powe; Josef Coresh
Journal:  Clin J Am Soc Nephrol       Date:  2012-06-28       Impact factor: 8.237

2.  Cystatin C in children on chronic hemodialysis.

Authors:  Olivera Marsenic; Andrea Wierenga; Donna R Wilson; Michael Anderson; Tripti Shrivastava; Garfield A Simon; Anne M Beck; Tiffany J Swanson; Kathleen Studnicka; Dorit Elberg; Kevin Couloures; Martin A Turman
Journal:  Pediatr Nephrol       Date:  2012-11-21       Impact factor: 3.714

Review 3.  Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children.

Authors:  Frederique Rodieux; Melanie Wilbaux; Johannes N van den Anker; Marc Pfister
Journal:  Clin Pharmacokinet       Date:  2015-12       Impact factor: 6.447

4.  Relationship between serum cystatin C and creatinine or dialysis adequacy in patients on chronic maintenance hemodialysis.

Authors:  Zhinoos Khorgami; Alireza Abdollahi; Samaneh Soleimani; Farrokhlagha Ahamadi; Mitra Mahdavi-Mazdeh
Journal:  Nephrourol Mon       Date:  2013-03-30

5.  Association of Plasma Uremic Solute Levels with Residual Kidney Function in Children on Peritoneal Dialysis.

Authors:  Lakshmi L Ganesan; Frank J O'Brien; Tammy L Sirich; Natalie S Plummer; Rita Sheth; Cecile Fajardo; Paul Brakeman; Scott M Sutherland; Timothy W Meyer
Journal:  Clin J Am Soc Nephrol       Date:  2021-07-07       Impact factor: 10.614

6.  Pitfalls in the Measurements and Assesment of Glomerular Filtration Rate and How to Escape them.

Authors:  Oliver Rácz; Ján Lepej; Bertalan Fodor; Katarína Lepejová; Peter Jarčuška; Anna Kováčová
Journal:  EJIFCC       Date:  2012-07-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.